Thymic epithelial tumors (TETs), comprising thymomas, thymic carcinomas, and thymic neuroendocrine neoplasms, are rare prevascular (anterior) mediastinal malignancies characterized by histologic and clinical heterogeneity. Their management is complex because of overlapping pathologic features, variable clinical behavior, frequent associations with autoimmune conditions, and lack of standardized therapeutic algorithms. This review addresses current challenges across the diagnosis, management, and treatment of TETs.
Journal of Thoracic Oncology (JTO) published a clinical update in Oncology on 10 Apr 2026.
The item focuses on Challenges and Controversies in the Diagnosis and Management of Thymic Epithelial Tumors from the Thymic Tumor Subcommittee of the International Association for the Study of Lung Cancer Rare Tumors Committee.
Review the original article for the full source wording and details.